Amedisys Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $71.23
- Today's High:
- $74.13
- Open Price:
- $74.13
- 52W Low:
- $79.3
- 52W High:
- $179.91
- Prev. Close:
- $73.43
- Volume:
- 352272
Company Statistics
- Market Cap.:
- $2.81 billion
- Book Value:
- 32.338
- Revenue TTM:
- $2.22 billion
- Operating Margin TTM:
- 8.27%
- Gross Profit TTM:
- $962.77 million
- Profit Margin:
- 5.34%
- Return on Assets TTM:
- 5.99%
- Return on Equity TTM:
- 11.3%
Company Profile
Amedisys Inc had its IPO on 1994-08-17 under the ticker symbol AMED.
The company operates in the Healthcare sector and Medical Care Facilities industry. Amedisys Inc has a staff strength of 20,000 employees.
Stock update
Shares of Amedisys Inc opened at $74.13 at the start of the last trading session i.e. 2023-03-30.
The stocks traded within a range of $71.23 - $74.13, and closed at $71.89.
This is a -2.1% slip from the previous day's closing price.
A total volume of 352,272 shares were traded at the close of the day’s session.
In the last one week, shares of Amedisys Inc have slipped by -0.96%.
Amedisys Inc's Key Ratios
Amedisys Inc has a market cap of $2.81 billion, indicating a price to book ratio of 2.7804 and a price to sales ratio of 1.2296.
In the last 12-months Amedisys Inc’s revenue was $2.22 billion with a gross profit of $962.77 million and an EBITDA of $208.72 million. The EBITDA ratio measures Amedisys Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Amedisys Inc’s operating margin was 8.27% while its return on assets stood at 5.99% with a return of equity of 11.3%.
In Q4, Amedisys Inc’s quarterly earnings growth was a negative -6.5% while revenue growth was a positive 0.5%.
Amedisys Inc’s PE and PEG Ratio
- Forward PE
- 16.1031
- Trailing PE
- 24.6686
- PEG
- 1.0741
Its diluted EPS in the last 12-months stands at $3.5 per share while it has a forward price to earnings multiple of 16.1031 and a PEG multiple of 1.0741. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Amedisys Inc’s profitability.
Amedisys Inc stock is trading at a EV to sales ratio of 1.5169 and a EV to EBITDA ratio of 13.0129. Its price to sales ratio in the trailing 12-months stood at 1.2296.
Amedisys Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $1.98 billion
- Total Liabilities
- $355.53 million
- Operating Cash Flow
- $-1866000.00
- Capital Expenditure
- $1.83 million
- Dividend Payout Ratio
- 0%
Amedisys Inc ended 2023 with $1.98 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $1.98 billion while shareholder equity stood at $1.05 billion.
Amedisys Inc ended 2023 with $20.41 million in deferred long-term liabilities, $355.53 million in other current liabilities, 38000.00 in common stock, $757.67 million in retained earnings and $1.29 billion in goodwill. Its cash balance stood at $40.54 million and cash and short-term investments were $40.54 million. The company’s total short-term debt was $49,017,000 while long-term debt stood at $419.42 million.
Amedisys Inc’s total current assets stands at $388.96 million while long-term investments were $60.50 million and short-term investments were $0. Its net receivables were $296.79 million compared to accounts payable of $43.74 million and inventory worth $0.
In 2023, Amedisys Inc's operating cash flow was $-1866000.00 while its capital expenditure stood at $1.83 million.
Comparatively, Amedisys Inc paid $0 in dividends in 2023.
Other key metrics
- Current Trading Price
- $71.89
- 52-Week High
- $179.91
- 52-Week Low
- $79.3
- Analyst Target Price
- $109.15
Amedisys Inc stock is currently trading at $71.89 per share. It touched a 52-week high of $179.91 and a 52-week low of $179.91. Analysts tracking the stock have a 12-month average target price of $109.15.
Its 50-day moving average was $87.25 and 200-day moving average was $99.76 The short ratio stood at 4.52 indicating a short percent outstanding of 0%.
Around 196.5% of the company’s stock are held by insiders while 9827.2% are held by institutions.
Frequently Asked Questions About Amedisys Inc
Similar Industry Stocks (Medical Care Facilities)
Most Active
Top Gainers
Top Losers
About
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through four segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer’s. The Personal Care segment provides assistance for patients with the activities of daily living. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.